| RS1210729449 |
PRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4 |
| RS1210737543 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome 1, Hereditary cancer-predisposing syndrome |
| RS1210749655 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1210751666 |
GZF1
|
Health Risk |
Pathogenic |
Joint laxity, short stature |
| RS1210762206 |
PYCR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 10, Hypomyelinating leukodystrophy 10 |
| RS1210764379 |
ANO10
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 10, Autosomal recessive spinocerebellar ataxia 10 |
| RS1210775452 |
CNGA3
|
Health Risk |
Likely pathogenic |
— |
| RS1210788594 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1210815997 |
GABRB2
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1210846081 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease |
| RS1210851910 |
AP4B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 47, Spastic paraplegia |
| RS1210874691 |
NPHP4
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Nephronophthisis 4 |
| RS1210887840 |
CARMIL2
|
Health Risk |
Pathogenic |
— |
| RS1210912397 |
COL7A1
|
Health Risk |
Pathogenic |
7 conditions, 7 conditions |
| RS1210919054 |
ACTA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 6 |
| RS1210934866 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
7 conditions, 7 conditions |
| RS1210940629 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS12109444 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1210953680 |
CCDC39
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1210956110 |
SON
|
Health Risk |
Conflicting classifications of pathogenicity |
ZTTK syndrome, ZTTK syndrome |
| RS1210957618 |
TPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS1210959281 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1210978043 |
CD46
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1210988336 |
DNAAF2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1210990672 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1210995618 |
DNAH1
|
Health Risk |
Likely pathogenic |
Spermatogenic failure 18, Ciliary dyskinesia |
| RS1210999092 |
DPAGT1
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS1211027535 |
DNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1211057639 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1211079280 |
PNPLA6
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 39, Laurence-Moon syndrome |
| RS1211098698 |
PROC
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1211112295 |
ASL
|
Health Risk |
Conflicting classifications of pathogenicity |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1211122898 |
GJC2
|
Health Risk |
Pathogenic |
— |
| RS1211144774 |
ERCC8
|
Health Risk |
Likely pathogenic |
Cockayne syndrome, Cockayne syndrome |
| RS1211156516 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1211193705 |
GLE1
|
Health Risk |
Likely pathogenic |
— |
| RS1211207020 |
RAD50
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1211210077 |
POLR3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukodystrophy, hypomyelinating |
| RS1211225273 |
EMC10
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with dysmorphic facies and variable seizures, Neurodevelopmental disorder with dysmorphic facies and variable seizures |
| RS1211232252 |
KAT6A
|
Health Risk |
Likely pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1211242747 |
RHOBTB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1211248610 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
TTN-related disorder, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1211262994 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1211288472 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS1211322465 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1211325812 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-childhood-onset retinal dystrophy, Retinitis pigmentosa |
| RS1211334325 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1211340506 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Inborn genetic diseases |
| RS1211360114 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1211363704 |
SLC45A2
|
Health Risk |
Conflicting classifications of pathogenicity |
SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR |
| RS1211378375 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
SYNE2-related disorder, Emery-Dreifuss muscular dystrophy 5 |
| RS1211389550 |
CEP104
|
Health Risk |
Pathogenic |
Joubert syndrome 25, Joubert syndrome 25 |
| RS1211397810 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS1211403432 |
LRSAM1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2P |
| RS1211433401 |
POLR3A
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS1211456697 |
LFNG
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 3, autosomal recessive |
| RS1211492911 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1211492964 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS1211499888 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 5 |
| RS1211534165 |
NGLY1
|
Health Risk |
Pathogenic |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation |
| RS1211539675 |
PHYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS1211553665 |
FBP1
|
Health Risk |
Pathogenic |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS1211561143 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1211579979 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1211592084 |
PPIB
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type 9, Osteogenesis imperfecta type 9 |
| RS1211592806 |
TMEM216
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 2 |
| RS1211601030 |
TGM1
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS1211616091 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1211627330 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1211629219 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS1211642532 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Colon adenocarcinoma |
| RS1211645093 |
CD40
|
Health Risk |
Pathogenic |
— |
| RS1211665230 |
CPT1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS1211675075 |
SGSH
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS1211684571 |
AARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1211734208 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1211739234 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculotrichoanal syndrome, Oculotrichoanal syndrome |
| RS1211739649 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1211773372 |
SLC13A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 25 |
| RS12117747 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS12118058 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease |
| RS1211845337 |
CNGA3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1211852182 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1211856182 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa |
| RS1211863124 |
STXBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 4 |
| RS1211875269 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Transitory neonatal diabetes mellitus, Maturity-onset diabetes of the young |
| RS1211886658 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Brittle cornea syndrome 1, Cardiovascular phenotype |
| RS1211886873 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1211890738 |
COL7A1
|
Health Risk |
Pathogenic |
Pretibial dystrophic epidermolysis bullosa, Epidermolysis bullosa dystrophica |
| RS1211905522 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS1211920866 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1211957325 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1211983012 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome |
| RS1212006965 |
DLG3
|
Health Risk |
Likely pathogenic |
— |
| RS1212010105 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1212026437 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS1212059076 |
AFF2
|
Health Risk |
Likely pathogenic |
FRAXE, FRAXE |
| RS1212081578 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1212090722 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS1212136611 |
GREB1L
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |